3-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study

Firas Zahr, Basel Ramlawi, Michael J. Reardon, G. Michael Deeb, Steven J. Yakubov, Howard K. Song, Neal S. Kleiman, Stanley J. Chetcuti, Hemal Gada, Mubashir Mumtaz, Stephane Leung, William Merhi, Joshua D. Rovin, Michael DeFrain, Murali Muppala, James Kauten, Vivek Rajagopal, Jiang Huang, Saki Ito, John K. Forrest